For Nutrition Awareness Month, we highlight the importance of tailoring dietary strategies to patients with cancer to improve ...

Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

This month’s Research Spotlight highlights significant advancements in pancreatic cancer research and patient support.

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

There are two main types of pancreatic cancers—those that start in the exocrine gland and those that start in the endocrine cells. Pancreatic cancer is a rare, but deadly disease. Treatment options ...

Pancreatic cancer is one of the most devastating cancers because it usually doesn’t exhibit symptoms until it’s too far advanced for effective treatment. As Pancreatic Cancer Action Network ex ...

Why This Matters Pancreatic cancer is one of the most difficult cancers to treat, with limited treatment options and a low survival rate. One reason for this is that pancreatic tumors don’t ...

The study, published in Science Advances, identifies the molecule Neuropeptide Y (NPY) as a key driver of pancreatic cancer metastasis – the process by which cancer spreads to other organs.

As few as one in ten people survive pancreatic cancer five years after their diagnosis — making it the most difficult cancer to survive. The survival rate five years after diagnosis is 6-14%, but ...

The genetic signatures of human tumours could be used to direct personalised pancreatic cancer treatment in the future. Mice were treated with 10 mg/kg rapamycin or vehicle daily by intraperitoneal ...